MRPL51

gene
On this page

Also known as CDA09HSPC241bMRP64mL51

Summary

MRPL51 (mitochondrial ribosomal protein L51, HGNC:14044) is a protein-coding gene on chromosome 12p13.31, encoding Large ribosomal subunit protein mL51 (Q4U2R6). It is a selective cancer dependency (DepMap: 29.3% of cell lines).

Mammalian mitochondrial ribosomal proteins are encoded by nuclear genes and help in protein synthesis within the mitochondrion. Mitochondrial ribosomes (mitoribosomes) consist of a small 28S subunit and a large 39S subunit. They have an estimated 75% protein to rRNA composition compared to prokaryotic ribosomes, where this ratio is reversed. Another difference between mammalian mitoribosomes and prokaryotic ribosomes is that the latter contain a 5S rRNA. Among different species, the proteins comprising the mitoribosome differ greatly in sequence, and sometimes in biochemical properties, which prevents easy recognition by sequence homology. This gene encodes a 39S subunit protein. Pseudogenes corresponding to this gene are found on chromosomes 4p and 21q.

Source: NCBI Gene 51258 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 32 total
  • Cancer dependency (DepMap): dependent in 29.3% of screened cell lines
  • MANE Select transcript: NM_016497

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:14044
Approved symbolMRPL51
Namemitochondrial ribosomal protein L51
Location12p13.31
Locus typegene with protein product
StatusApproved
AliasesCDA09, HSPC241, bMRP64, mL51
Ensembl geneENSG00000111639
Ensembl biotypeprotein_coding
OMIM611855
Entrez51258

Gene structure

Transcript identifiers

Ensembl transcripts: 8 — 8 protein_coding

ENST00000229238, ENST00000537701, ENST00000538814, ENST00000540949, ENST00000543164, ENST00000543703, ENST00000543959, ENST00000925507

RefSeq mRNA: 1 — MANE Select: NM_016497 NM_016497

CCDS: CCDS8547

Canonical transcript exons

ENST00000229238 — 3 exons

ExonStartEnd
ENSE0000086691664930586493262
ENSE0000231587164918866492467
ENSE0000367942364928626492972

Expression profiles

Bgee: expression breadth ubiquitous, 263 present calls, max score 99.31.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 112.9786 / max 1861.4228, expressed in 1825 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
12910398.94811824
12910511.84811780
1291042.18251297

Top tissues by expression

263 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
left ventricle myocardiumUBERON:000656699.31gold quality
kidney epitheliumUBERON:000481999.30gold quality
right testisUBERON:000453499.26gold quality
left testisUBERON:000453399.25gold quality
upper arm skinUBERON:000426399.15gold quality
ileal mucosaUBERON:000033199.11gold quality
cardiac muscle of right atriumUBERON:000337999.06gold quality
tibialis anteriorUBERON:000138598.93gold quality
myocardiumUBERON:000234998.88gold quality
skeletal muscle tissue of rectus abdominisUBERON:000451198.64gold quality
quadriceps femorisUBERON:000137798.55gold quality
heart left ventricleUBERON:000208498.55gold quality
cardiac ventricleUBERON:000208298.54gold quality
vastus lateralisUBERON:000137998.51gold quality
deltoidUBERON:000147698.47gold quality
islet of LangerhansUBERON:000000698.42gold quality
testisUBERON:000047398.42gold quality
apex of heartUBERON:000209898.41gold quality
adult organismUBERON:000702398.40gold quality
cardiac atriumUBERON:000208198.38gold quality
heartUBERON:000094898.36gold quality
right atrium auricular regionUBERON:000663198.36gold quality
gastrocnemiusUBERON:000138898.33gold quality
hindlimb stylopod muscleUBERON:000425298.31gold quality
skeletal muscle organUBERON:001489298.30gold quality
muscle of legUBERON:000138398.28gold quality
heart right ventricleUBERON:000208098.27gold quality
muscle tissueUBERON:000238598.26gold quality
mucosa of transverse colonUBERON:000499198.26gold quality
skeletal muscle tissueUBERON:000113498.24gold quality

Single-cell (SCXA)

Detected in 6 experiment(s), a significant marker in 3.

ExperimentMarker?Max mean expression
E-MTAB-9467yes33.22
E-CURD-122yes16.22
E-GEOD-81383no531.69
E-GEOD-110499no446.19
E-MTAB-7037no439.54
E-ANND-3no0.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

8 targeting MRPL51, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-391999.8769.452489
HSA-MIR-556-3P99.7468.751203
HSA-MIR-10399-5P99.1769.872610
HSA-MIR-6504-3P99.1769.312891
HSA-MIR-670-3P99.0368.882404
HSA-MIR-5088-3P98.2966.631310
HSA-MIR-3189-5P97.5566.71655
HSA-MIR-432393.9363.89656

Functional genomics

DepMap (CRISPR cell-line fitness): dependent in 29.3% of screened cell lines.

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
danio_reriomrpl51ENSDARG00000041340
mus_musculusMrpl51ENSMUSG00000030335
rattus_norvegicusMrpl51ENSRNOG00000019165
drosophila_melanogastermRpL51FBGN0032053
caenorhabditis_elegansWBGENE00011740

Protein

Protein identifiers

Large ribosomal subunit protein mL51Q4U2R6 (reviewed: Q4U2R6)

Alternative names: 39S ribosomal protein L51, mitochondrial, bMRP-64

All UniProt accessions (4): Q4U2R6, A0A087WU28, A0A0B4J2C1, M0R176

UniProt curated annotations — full annotation on UniProt →

Subunit / interactions. Component of the mitochondrial large ribosomal subunit (mt-LSU). Mature mammalian 55S mitochondrial ribosomes consist of a small (28S) and a large (39S) subunit. The 28S small subunit contains a 12S ribosomal RNA (12S mt-rRNA) and 30 different proteins. The 39S large subunit contains a 16S rRNA (16S mt-rRNA), a copy of mitochondrial valine transfer RNA (mt-tRNA(Val)), which plays an integral structural role, and 52 different proteins. Interacts with OXA1L.

Subcellular location. Mitochondrion.

Similarity. Belongs to the mitochondrion-specific ribosomal protein mL51 family.

RefSeq proteins (1): NP_057581* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR019373Ribosomal_mL51Family

Pfam: PF10244

UniProt features (13 total): helix 7, turn 2, transit peptide 1, chain 1, sequence variant 1, sequence conflict 1

Structure

Experimental structures (PDB)

85 structures, top 30 by resolution.

PDBMethodResolution (Å)
7OF0ELECTRON MICROSCOPY2.2
7QI4ELECTRON MICROSCOPY2.21
8RRIELECTRON MICROSCOPY2.4
8QU5ELECTRON MICROSCOPY2.42
9OLFELECTRON MICROSCOPY2.46
7OF7ELECTRON MICROSCOPY2.5
7PO4ELECTRON MICROSCOPY2.56
6ZM6ELECTRON MICROSCOPY2.59
7O9MELECTRON MICROSCOPY2.6
7OF6ELECTRON MICROSCOPY2.6
9CN3ELECTRON MICROSCOPY2.62
7QI5ELECTRON MICROSCOPY2.63
7OF2ELECTRON MICROSCOPY2.7
7OF3ELECTRON MICROSCOPY2.7
7OF4ELECTRON MICROSCOPY2.7
9PR4ELECTRON MICROSCOPY2.77
9PRAELECTRON MICROSCOPY2.83
8ANYELECTRON MICROSCOPY2.85
6ZM5ELECTRON MICROSCOPY2.89
7QH7ELECTRON MICROSCOPY2.89
7ODRELECTRON MICROSCOPY2.9
7OF5ELECTRON MICROSCOPY2.9
8K2AELECTRON MICROSCOPY2.9
8OITELECTRON MICROSCOPY2.9
9PGLELECTRON MICROSCOPY2.9
9PGFELECTRON MICROSCOPY2.93
6VMIELECTRON MICROSCOPY2.96
6VLZELECTRON MICROSCOPY2.97
7QI6ELECTRON MICROSCOPY2.98
9PSMELECTRON MICROSCOPY2.98

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q4U2R6-F186.800.71

Function

Pathways and Gene Ontology

Reactome pathways

7 pathways

IDPathway
R-HSA-5368286Mitochondrial translation initiation
R-HSA-5389840Mitochondrial translation elongation
R-HSA-5419276Mitochondrial translation termination
R-HSA-9937383Mitochondrial ribosome-associated quality control
R-HSA-392499Metabolism of proteins
R-HSA-5368287Mitochondrial translation
R-HSA-72766Translation

MSigDB gene sets: 152 (showing top): STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN, GOBP_MITOCHONDRIAL_TRANSLATION, GOBP_TRANSLATION, CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1, GOMF_STRUCTURAL_CONSTITUENT_OF_RIBOSOME, GOCC_MITOCHONDRIAL_ENVELOPE, ACEVEDO_LIVER_CANCER_UP, BURTON_ADIPOGENESIS_6, GOCC_LARGE_RIBOSOMAL_SUBUNIT, GOCC_RIBOSOME, GCCATNTTG_YY1_Q6, GOCC_ORGANELLAR_RIBOSOME, GOCC_MITOCHONDRIAL_MATRIX, GOCC_ORGANELLE_INNER_MEMBRANE, MARSON_BOUND_BY_E2F4_UNSTIMULATED

GO Biological Process (2): translation (GO:0006412), mitochondrial translation (GO:0032543)

GO Molecular Function (2): structural constituent of ribosome (GO:0003735), protein binding (GO:0005515)

GO Cellular Component (6): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), mitochondrial ribosome (GO:0005761), mitochondrial large ribosomal subunit (GO:0005762), ribosome (GO:0005840), ribonucleoprotein complex (GO:1990904)

Reactome top-level categories

Rollup of top-3 pathways:

CategoryPathways
Mitochondrial translation4
Translation1
Metabolism of proteins1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
peptidyltransferase activity1
translational initiation1
translational elongation1
translational termination1
macromolecule biosynthetic process1
protein metabolic process1
protein biosynthetic process1
mitochondrion1
translation1
mitochondrial gene expression1
structural molecule activity1
ribosome1
binding1
cytoplasm1
intracellular membrane-bounded organelle1
organelle inner membrane1
mitochondrial membrane1
organellar ribosome1
mitochondrial matrix1
organellar large ribosomal subunit1
mitochondrial ribosome1
mitochondrial protein-containing complex1
intracellular membraneless organelle1
protein-containing complex1

Protein interactions and networks

STRING

1530 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
MRPL51MRPL48Q96GC5710
MRPL51MRPL49Q13405692
MRPL51MRPL20Q9BYC9689
MRPL51MRPS21P82921625
MRPL51MRPS25P82663624
MRPL51MRPL55Q7Z7F7614
MRPL51NDUFA1O15239591
MRPL51MRPS14O60783525
MRPL51MRPS18CQ9Y3D5522
MRPL51MRPL50Q8N5N7510
MRPL51ZSWIM7Q19AV6493
MRPL51MRPS30Q9NP92493
MRPL51PPP4R3BQ5MIZ7490
MRPL51COA5Q86WW8479
MRPL51GCSHP23434474

IntAct

90 interactions, top by confidence:

ABTypeScore
MRPL37HSPD1psi-mi:“MI:0914”(association)0.710
MRPS30GTPBP10psi-mi:“MI:0914”(association)0.640
MRPL50GTPBP10psi-mi:“MI:0914”(association)0.530
RPL18NOP56psi-mi:“MI:0914”(association)0.530
MRPL10ZZEF1psi-mi:“MI:0914”(association)0.530
MRPL42GATCpsi-mi:“MI:0914”(association)0.530
PDGFBDKC1psi-mi:“MI:0914”(association)0.530
MRPL41MRPL3psi-mi:“MI:0914”(association)0.530
MRPL13GTPBP10psi-mi:“MI:0914”(association)0.530
MRPL18GTPBP10psi-mi:“MI:0914”(association)0.530
NDUFAB1MIEF1psi-mi:“MI:0915”(physical association)0.490
MRPL50MRPL43psi-mi:“MI:0914”(association)0.350
MRPL9MRPL43psi-mi:“MI:0914”(association)0.350
FOXB1DDX39Apsi-mi:“MI:0914”(association)0.350
HSCBRBP5psi-mi:“MI:0914”(association)0.350
HIF1ANARID1Apsi-mi:“MI:0914”(association)0.350
ALYREFpsi-mi:“MI:0914”(association)0.350
MRPL4ZSWIM8psi-mi:“MI:0914”(association)0.350
MRPL12psi-mi:“MI:0914”(association)0.350
RPS8RRP8psi-mi:“MI:0914”(association)0.350
MRPL39PTCD1psi-mi:“MI:0914”(association)0.350
MRPL47MRPL33psi-mi:“MI:0914”(association)0.350
ATAD3ATMEM223psi-mi:“MI:0914”(association)0.350
PSME3C11orf98psi-mi:“MI:0914”(association)0.350
rl36a_rl36l_humanIPO5psi-mi:“MI:0914”(association)0.350
H1-7psi-mi:“MI:0914”(association)0.350
PIPSLC1orf226psi-mi:“MI:0914”(association)0.350
S100A2PLEKHG3psi-mi:“MI:0914”(association)0.350
FTLSH3PXD2Bpsi-mi:“MI:0914”(association)0.350

BioGRID (189): MRPL51 (Affinity Capture-MS), MRPL51 (Affinity Capture-MS), MRPL51 (Affinity Capture-MS), MRPL51 (Affinity Capture-MS), MRPL51 (Affinity Capture-MS), MRPL51 (Co-fractionation), MRPL51 (Affinity Capture-MS), MRPL51 (Affinity Capture-MS), MRPL51 (Affinity Capture-MS), MRPL51 (Affinity Capture-MS), MRPL51 (Affinity Capture-MS), MRPL51 (Affinity Capture-MS), MRPL51 (Affinity Capture-MS), MRPL51 (Affinity Capture-MS), MRPL51 (Affinity Capture-MS)

ESM2 similar proteins: A1TYV1, A3M7E7, A4SHF6, A7HUX6, A7IDK1, A8IM57, A9HHS1, A9L948, B0VBX6, B0VUE9, B1VFG4, B2HVM2, B2ICM8, B4RYA0, B6INQ0, B7GZ34, B7I4A2, B8EK30, B8H4M5, C1D0Z8, G2TRQ8, O14187, P00129, P16135, P90993, Q02950, Q15N51, Q1GDB7, Q22438, Q28GD1, Q29PG4, Q2G8J9, Q2RVH2, Q4U2R6, Q5BJJ8, Q5FNB8, Q5ZKG1, Q61SE7, Q66KZ3, Q6CAD1

Diamond homologs: P0C2B6, Q28GD1, Q29PG4, Q4U2R6, Q5BJJ8, Q5ZKG1, Q66KZ3, Q9CPY1, Q9VLJ9, Q22438, Q61SE7

SIGNOR signaling

1 interactions.

AEffectBMechanism
MRPL51“form complex”“39S mitochondrial large ribosomal subunit”binding

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 95 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Mitochondrial ribosome-associated quality control2548.7×6e-35
Mitochondrial translation initiation2346.3×9e-32
Mitochondrial translation elongation2346.3×9e-32
Mitochondrial translation2145.9×6e-29
Mitochondrial translation termination2340.1×3e-30
Translation2221.7×9e-23
Regulation of expression of SLITs and ROBOs66.6×6e-03

GO biological processes:

GO termPartnersFoldFDR
mitochondrial translation2552.3×1e-34
translation1822.3×2e-17

Disease & clinical

Clinical variants and AI predictions

ClinVar

32 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance21
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

421 predictions. Top by Δscore:

VariantEffectΔscore
12:6492857:CTTA:Cdonor_loss1.0000
12:6492858:TTAC:Tdonor_loss1.0000
12:6492859:TA:Tdonor_loss1.0000
12:6492860:A:ACdonor_gain1.0000
12:6492860:A:AGdonor_loss1.0000
12:6492860:AC:Adonor_gain1.0000
12:6492861:C:CCdonor_gain1.0000
12:6492861:CC:Cdonor_gain1.0000
12:6492970:CAC:Cacceptor_gain1.0000
12:6492971:ACC:Aacceptor_loss1.0000
12:6492973:C:CAacceptor_loss1.0000
12:6492974:T:Gacceptor_loss1.0000
12:6493362:T:TAdonor_gain1.0000
12:6492468:C:CAacceptor_loss0.9900
12:6492468:C:CCacceptor_gain0.9900
12:6492469:T:Gacceptor_loss0.9900
12:6492470:G:GCacceptor_gain0.9900
12:6492968:CACAC:Cacceptor_gain0.9900
12:6492969:ACAC:Aacceptor_gain0.9900
12:6492970:CACC:Cacceptor_gain0.9900
12:6492973:C:CCacceptor_gain0.9900
12:6492979:A:ACacceptor_gain0.9900
12:6493343:C:Adonor_gain0.9900
12:6493347:T:TAdonor_gain0.9900
12:6493348:C:Adonor_gain0.9900
12:6493463:T:Adonor_gain0.9900
12:6493826:G:GTdonor_gain0.9900
12:6492463:GTTTC:Gacceptor_gain0.9800
12:6492464:TTTC:Tacceptor_gain0.9800
12:6492465:TTC:Tacceptor_gain0.9800

AlphaMissense

839 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
12:6492423:A:GW79R0.993
12:6492423:A:TW79R0.993
12:6492389:C:GR90P0.992
12:6492376:C:AK94N0.989
12:6492376:C:GK94N0.989
12:6492913:A:GW47R0.989
12:6492913:A:TW47R0.989
12:6492380:C:GR93P0.988
12:6492867:A:GI62T0.987
12:6492879:T:AD58V0.984
12:6492890:G:CF54L0.983
12:6492890:G:TF54L0.983
12:6492892:A:GF54L0.983
12:6492878:G:CD58E0.981
12:6492878:G:TD58E0.981
12:6492879:T:GD58A0.981
12:6492888:C:TG55E0.981
12:6492290:C:GR123P0.980
12:6492395:A:GL88S0.980
12:6492411:A:GW83R0.980
12:6492411:A:TW83R0.980
12:6492911:C:AW47C0.980
12:6492911:C:GW47C0.980
12:6492419:A:TL80H0.979
12:6492320:C:GR113P0.976
12:6492421:C:AW79C0.976
12:6492421:C:GW79C0.976
12:6492329:A:GL110P0.975
12:6492419:A:GL80P0.975
12:6492467:C:AG64V0.975

dbSNP variants (sampled 300 via entrez): RS1001090844 (12:6491647 C>G), RS1001125 (12:6492808 T>C), RS1001126 (12:6492736 A>G), RS1001127 (12:6492577 A>C,T), RS1001266777 (12:6493647 G>A,T), RS1001297938 (12:6493411 C>A,T), RS1002324800 (12:6492466 T>A,G), RS1002986437 (12:6494756 G>A,C,T), RS1003331385 (12:6493622 C>T), RS1003614727 (12:6494735 T>A), RS1003645862 (12:6494423 C>T), RS1003862728 (12:6494853 C>T), RS1005525257 (12:6493669 G>A), RS1005663579 (12:6492575 G>A,C), RS1006014178 (12:6493835 G>A,T)

Disease associations

OMIM: gene MIM:611855 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

28 total (human), top 28 by PubMed support.

ChemicalActions (top 5)PubMed papers
Leflunomidedecreases expression2
aristolochic acid Iincreases expression1
bisphenol Faffects cotreatment, increases expression1
dicrotophosdecreases expression1
beta-lapachonedecreases expression1
arseniteaffects binding, increases reaction1
tris(1,3-dichloro-2-propyl)phosphatedecreases expression1
sodium arseniteincreases expression1
di-n-butylphosphoric acidaffects expression1
chloropicrinincreases expression1
K 7174decreases expression1
ICG 001increases expression1
Acetaminophenaffects cotreatment, decreases expression1
Air Pollutants, Occupationaldecreases expression1
Cadmiumincreases abundance, increases expression1
Dexamethasoneaffects cotreatment, increases expression1
Doxorubicinincreases expression1
Indomethacinaffects cotreatment, increases expression1
Leadaffects expression1
Lipopolysaccharidesaffects cotreatment, decreases expression1
Nickeldecreases expression1
Ribonucleotidesaffects binding1
Thiramdecreases expression1
Valproic Aciddecreases methylation1
1-Methyl-3-isobutylxanthineaffects cotreatment, increases expression1
Antirheumatic Agentsincreases expression1
Cadmium Chlorideincreases abundance, increases expression1
Copper Sulfatedecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.